Integrated BioPharma, Inc. (INBP)
0.182
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Integrated BioPharma Shareholders Equity (Quarterly) : 17.67M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.67M |
| March 31, 2026 | 18.98M |
| December 31, 2025 | 19.77M |
| September 30, 2025 | 20.49M |
| June 30, 2025 | 20.32M |
| March 31, 2025 | 20.38M |
| December 31, 2024 | 19.73M |
| September 30, 2024 | 19.55M |
| June 30, 2024 | 19.24M |
| March 31, 2024 | 18.91M |
| December 31, 2023 | 18.57M |
| September 30, 2023 | 18.89M |
| June 30, 2023 | 18.86M |
| March 31, 2023 | 18.74M |
| December 31, 2022 | 18.65M |
| September 30, 2022 | 18.62M |
| June 30, 2022 | 18.58M |
| March 31, 2022 | 16.98M |
| December 31, 2021 | 16.07M |
| September 30, 2021 | 14.89M |
| June 30, 2021 | 14.33M |
| March 31, 2021 | 9.749M |
| December 31, 2020 | 8.433M |
| September 30, 2020 | 7.116M |
| June 30, 2020 | 6.067M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.144M |
| December 31, 2019 | 3.194M |
| September 30, 2019 | 2.22M |
| June 30, 2019 | 1.893M |
| March 31, 2019 | 1.389M |
| December 31, 2018 | 0.466M |
| September 30, 2018 | 0.195M |
| June 30, 2018 | -5.236M |
| March 31, 2018 | -6.056M |
| December 31, 2017 | -6.447M |
| September 30, 2017 | -6.104M |
| June 30, 2017 | -5.929M |
| March 31, 2017 | -7.477M |
| December 31, 2016 | -7.73M |
| September 30, 2016 | -7.674M |
| June 30, 2016 | -8.327M |
| March 31, 2016 | -9.081M |
| December 31, 2015 | -9.121M |
| September 30, 2015 | -9.065M |
| June 30, 2015 | -9.316M |
| March 31, 2015 | -9.309M |
| December 31, 2014 | -9.203M |
| September 30, 2014 | -9.752M |
| June 30, 2014 | -10.16M |
| March 31, 2014 | -10.04M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Medifast, Inc. | 196.38M |
| Skinvisible, Inc. | -10.79M |
| Nevis Brands, Inc. | 0.6951M |
| Functional Brands, Inc. | -2.955M |
| Cyanotech Corp. | 7.985M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.34M |
| Total Liabilities (Quarterly) | 7.671M |
| Debt to Equity Ratio | 0.1742 |
| Current Ratio | 2.995 |
| Net Debt Paydown Yield | -6.96% |